Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1990 1
1991 2
1992 1
1994 1
1996 1
2001 1
2015 2
2017 1
2018 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for c. mazingue
Your search for c. maringue retrieved no results
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Lutz P, Mechinaud F, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behard C, Plantaz D, Dresse MF, Philippet P, Norton L, Thyss A, Dastugue N, Waterkeyn C, Vilmer E, Otten J; Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer. Millot F, et al. J Clin Oncol. 2001 Apr 1;19(7):1935-42. doi: 10.1200/JCO.2001.19.7.1935. J Clin Oncol. 2001. PMID: 11283125 Free article. Clinical Trial.
RESULTS: Between January 1990 and January 1996, 653 patients with ALL (593 patients) or lymphoblastic lymphoma (60 patients) were randomized: 323 were assigned to Arm A (without Ara-C) and 330 to Arm B (with Ara-C). A total of 190 events (177 relapses and 13 deaths …
RESULTS: Between January 1990 and January 1996, 653 patients with ALL (593 patients) or lymphoblastic lymphoma (60 patients) were randomized …
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.
Piette C, Suciu S, Clappier E, Bertrand Y, Drunat S, Girard S, Yakouben K, Plat G, Dastugue N, Mazingue F, Grardel N, van Roy N, Uyttebroeck A, Costa V, Minckes O, Sirvent N, Simon P, Lutz P, Ferster A, Pluchart C, Poirée M, Freycon C, Dresse MF, Millot F, Chantrain C, van der Werff Ten Bosch J, Norga K, Gilotay C, Rohrlich PS, Benoit Y, Cavé H. Piette C, et al. Leukemia. 2018 Jan;32(1):244-248. doi: 10.1038/leu.2017.289. Epub 2017 Sep 19. Leukemia. 2018. PMID: 29064485 Free article. No abstract available.
Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?
Delebarre M, Garnier N, Macher E, Thebaud E, Mazingue F, Leblond P, Duhamel A, Martinot A, Dubos F. Delebarre M, et al. J Pediatr Hematol Oncol. 2015 Nov;37(8):e468-74. doi: 10.1097/MPH.0000000000000440. J Pediatr Hematol Oncol. 2015. PMID: 26479996
Variables predictive of severe infection at admission were: disease with high risk of prolonged neutropenia (adjusted odds ratio [aOR]=2.5), blood cancer (aOR=1.9), fever 38.5 C (aOR=3.7), and C-reactive protein level 90 mg/L (aOR=4.5). Now that we have identified …
Variables predictive of severe infection at admission were: disease with high risk of prolonged neutropenia (adjusted odds ratio [aOR]=2.5), …
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.
Jourdain A, Auperin A, Minard-Colin V, Aladjidi N, Zsiros J, Coze C, Gandemer V, Bertrand Y, Leverger G, Bergeron C, Michon J, Patte C; SFCE LNH Committee. Jourdain A, et al. Haematologica. 2015 Jun;100(6):810-7. doi: 10.3324/haematol.2014.121434. Epub 2015 Feb 27. Haematologica. 2015. PMID: 25724577 Free PMC article.
Three patients were initially treated in risk group A, 41 in group B and 23 in group C. Thirty-three patients had a relapse in one site (15 in the central nervous system) and 34 at multiple sites. ...
Three patients were initially treated in risk group A, 41 in group B and 23 in group C. Thirty-three patients had a relapse in one si …
Induction of antibodies against the Plasmodium falciparum p126 antigen in non-responder H-2b and partial-responder H-2d mice using synthetic peptides.
Gilardeau Truffinet M, Bossus M, Camus D, Delplace P, Mazingue C, Diesis E, Tartar A, Moreau S, Gras-Masse H, Banic DM. Gilardeau Truffinet M, et al. Pept Res. 1996 Mar-Apr;9(2):61-70. Pept Res. 1996. PMID: 8738980
Synthetic peptides corresponding to the N-terminus of p50 or p18 as well as to the C-terminus of p47 were unable to induce anti-peptide antibodies when injected carrier-free or coupled to ovalbumin. Synthetic peptides corresponding to the C-terminus of p18 or compos …
Synthetic peptides corresponding to the N-terminus of p50 or p18 as well as to the C-terminus of p47 were unable to induce anti-pepti …
Schistosome-derived inhibitory factor: an immunosuppressive agent preferentially active on T lymphocytes.
Mazingue C, Stadler BM, Quatannens B, Capron A, de Weck A. Mazingue C, et al. Int Arch Allergy Appl Immunol. 1986;80(4):347-54. doi: 10.1159/000234080. Int Arch Allergy Appl Immunol. 1986. PMID: 3488275
SDIF-activity was absorbed by cells in a time- and cell-number-dependent fashion at 4 degrees C, suggesting the existence of a possible receptor for SDIF. However, the difference in sensitivity to SDIF proliferation inhibition could not be attributed to the presence or abs …
SDIF-activity was absorbed by cells in a time- and cell-number-dependent fashion at 4 degrees C, suggesting the existence of a possib …
H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.
Banic DM, Delplace P, Mazingue C, Camus D. Banic DM, et al. Clin Exp Immunol. 1994 Mar;95(3):472-8. doi: 10.1111/j.1365-2249.1994.tb07021.x. Clin Exp Immunol. 1994. PMID: 8137542 Free PMC article.
Inbred BALB/c (H-2d), CBA (H-2k) and C57B1/6 (H-2b) mice immunized with Plasmodium falciparum schizonts or culture supernates develop antibodies of different antigenic specificities. ...Lymphocyte proliferation assays performed by incubation of spleen cells with immunopuri …
Inbred BALB/c (H-2d), CBA (H-2k) and C57B1/6 (H-2b) mice immunized with Plasmodium falciparum schizonts or culture supernates develop …
T-cell responsiveness towards various synthetic peptides of the P28 antigen in rat and mouse models during Schistosoma mansoni infection.
Wolowczuk I, Auriault C, Gras-Masse H, Mazingue C, Vendeville C, Tartar A, Capron A. Wolowczuk I, et al. Int Arch Allergy Appl Immunol. 1990;93(4):350-8. doi: 10.1159/000235265. Int Arch Allergy Appl Immunol. 1990. PMID: 1713570
In order to analyze whether these located determinants were also exposed to the host's immune system during the natural S. mansoni infection or after immunization with crude antigenic extracts of various development stages of the parasite, the T-cell responsiveness of infected or …
In order to analyze whether these located determinants were also exposed to the host's immune system during the natural S. mansoni infection …
12 results